MJ
Monson Jonathan
Vice-Président, Contrôleur Global et Directeur Administratif
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Monson Jonathan, Vice-Président, Contrôleur Global et Directeur Administratif. Insider active across 1 company, notably Boston Scientific CORP. Cumulatively, 24 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €315k. Activity tracked since 14 June 2021. The latest transaction was disclosed on 10 August 2026 (I). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Monson Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报24 总计
9,908 股@ US$50.460.0007% mcap46.9% 占其流量Common StockSEC:0001225208-26-007062:0
2,087 股Common StockSEC:0001225208-26-006362:0
1,010 股Common StockSEC:0001225208-26-006362:1
1,766 股0Common StockSEC:0001225208-26-002136:0
1,154 股0Common StockSEC:0001225208-26-002017:0
1,090 股0Common StockSEC:0001225208-25-006988:0
990 股0Common StockSEC:0001225208-24-002578:0
1,057 股0Common StockSEC:0001225208-24-002307:0
1,090 股0Common StockSEC:0001225208-23-007928:0
729 股0Common StockSEC:0001225208-23-007118:0
5,000 股@ US$12.896.9% 占其流量Common StockSEC:0001225208-23-004333:0
5,000 股@ US$12.897.1% 占其流量Common StockSEC:0001225208-23-003165:0
623 股0Common StockSEC:0001225208-23-002533:0
990 股0Common StockSEC:0001225208-23-002380:0
739 股0Common StockSEC:0001225208-23-002155:0
1,089 股0Common StockSEC:0001225208-22-009191:0
728 股0Common StockSEC:0001225208-22-008662:0
815 股0Common StockSEC:0001225208-22-003864:0
623 股0Common StockSEC:0001225208-22-003083:0
1,000 股0Common StockSEC:0001225208-22-002923:0
738 股0Common StockSEC:0001225208-22-002679:0
728 股0Common StockSEC:0001225208-21-010273:0
8,833 股@ US$42.76464.4% 占其流量Common StockSEC:0001225208-21-009506:0
5,000 股@ US$13.0811.0% 占其流量Common StockSEC:0001225208-21-009468:0
About Monson Jonathan
Monson Jonathan is Vice-President, Global Controller and Administrative Director. He is associated with Boston Scientific CORP, and his 23 filings cover, in the recent filing sample available, transactions between 2021-06-16 and 2026-07-02, with EUR 314894 in sales and no reported buys.